Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CLEXANE for Deep vein thrombosis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 6 adverse event reports in the FDA FAERS database where CLEXANE was used for Deep vein thrombosis.

Most Reported Side Effects for CLEXANE

Side Effect Reports % Deaths Hosp.
Exposure during pregnancy 28 19.2% 0 8
Anaemia 14 9.6% 5 9
Haemorrhage 12 8.2% 8 4
Renal failure 9 6.2% 8 2
Tachycardia 9 6.2% 0 9
Abortion spontaneous 8 5.5% 0 0
Cerebellar haemorrhage 8 5.5% 0 7
Foetal exposure during pregnancy 7 4.8% 1 5
Melaena 7 4.8% 4 3
Hepatic enzyme increased 6 4.1% 0 0
Pulmonary embolism 6 4.1% 4 1
Death 5 3.4% 5 2
Haematemesis 5 3.4% 4 1
Hypotension 5 3.4% 4 0
Premature baby 5 3.4% 1 4

Other Indications for CLEXANE

Thrombosis prophylaxis (35) Product used for unknown indication (27) Prophylaxis (13) Hypercoagulation (7) Atrial fibrillation (6) Maternal exposure timing unspecified (6)

Other Drugs Used for Deep vein thrombosis

RIVAROXABAN (17,913) APIXABAN (6,535) WARFARIN (2,294) ENOXAPARIN (1,209) DABIGATRAN ETEXILATE (668) HEPARIN (603) XARELTO (506) EDOXABAN (404) ASPIRIN (356) DALTEPARIN (191)

Related Pages

CLEXANE Full Profile All Deep vein thrombosis Drugs CLEXANE Demographics CLEXANE Timeline